V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012988 | 330008347 | 1.84 | 68.9 | Palliative (P) | 2018-02-18 | 2018-02-18 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330011029 | MAP |
| 330012989 | 330004302 | 1.83 | null | Palliative (P) | 2013-02-27 | 2013-09-17 | DOCETAXEL + GEMCITABINE | 02 | null | 330011097 | DOCETAXEL + GEMCITABINE |
| 330012990 | 330004308 | 1.74 | 55.4 | Curative (C) | 2018-06-14 | 2018-07-25 | Carboplatin AUC 2 - 5 | 2 | N | 330011197 | CARBOPLATIN |
| 330012992 | 330004329 | null | 65.4 | Curative (C) | 2017-02-17 | 2017-02-22 | PAM x 2 post-surgery (cycles 3&4) | null | null | 330011340 | MAP |
| 330012993 | 330004344 | null | 93.7 | Curative (C) | 2016-09-19 | 2017-02-17 | Carboplatin AUC 6 - 10 | N | N | 330011479 | CARBOPLATIN |
| 330012994 | 330004353 | 1.73 | 61 | Palliative (P) | 2019-06-04 | 2019-07-13 | CETUXIMAB | N | N | 330011513 | CETUXIMAB |
| 330012995 | 330008382 | 1.68 | 48.6 | Palliative (P) | 2018-09-15 | 2019-01-06 | Docetaxel + Gemcitabine (prior RT) | N | N | 330011603 | DOCETAXEL + GEMCITABINE |
| 330012996 | 330008422 | 1.8 | 99 | Curative (C) | 2018-10-04 | 2018-10-04 | BENDAMUSTINE + RITUXIMAB | N | Y | 330011964 | BENDAMUSTINE + RITUXIMAB |
| 330012997 | 330004449 | 1.72 | 15.7 | Disease modification (D) | 2019-01-22 | 2019-03-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011981 | BENDAMUSTINE + RITUXIMAB |
| 330012998 | 330004517 | 1.7 | 67.1 | Neo-adjuvant (N) | 2015-10-29 | 2015-11-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012305 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012999 | 330004549 | 1.6 | 60.2 | Curative (C) | 2018-05-09 | 2018-05-16 | CARBOPLATIN + RT | N | N | 330012411 | CARBOPLATIN + RT |
| 330013000 | 330004579 | 1.5 | null | Palliative (P) | 2018-08-08 | 2018-08-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012557 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330013001 | 330004601 | null | 86 | Palliative (P) | 2019-10-17 | 2019-10-17 | Cetuximab + Radiotherapy Maint | N | Y | 330012634 | CETUXIMAB + RT |
| 330013002 | 330004652 | 1.75 | 3.4 | Curative (C) | 2016-10-12 | 2017-08-01 | EURAMOS TRIAL | N | N | 330012860 | EURAMOS TRIAL |
| 330013003 | 330008543 | null | 52.3 | Palliative (P) | 2019-03-13 | 2019-05-12 | VAI (Ifos 3g/m2) | N | N | 330012935 | VAI |
| 330013004 | 330004675 | 1.88 | 84.85 | Disease modification (D) | 2017-07-28 | 2017-07-28 | CARBOPLATIN + RT | 02 | N | 330012987 | CARBOPLATIN + RT |
| 330013005 | 330004684 | 1.61 | 56.4 | Curative (C) | 2018-09-22 | 2018-10-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013060 | BENDAMUSTINE + RITUXIMAB |
| 330013006 | 330004712 | 1.62 | 85.4 | Curative (C) | null | 2015-11-10 | CARBOPLATIN + RT | 02 | N | 330013142 | CARBOPLATIN + RT |
| 330013007 | 330012822 | null | null | Not known (9) | 2015-08-11 | 2015-08-11 | Cetuximab + Radiotherapy Maint | 02 | N | 330013156 | CETUXIMAB + RT |
| 330013008 | 330004732 | 1.57 | 69 | Palliative (P) | 2015-08-08 | 2015-08-19 | Bendamustine+Rituximab (1st Course) | N | null | 330013234 | BENDAMUSTINE + RITUXIMAB |
| 330013009 | 330004738 | null | 51.8 | Palliative (P) | 2018-05-23 | 2018-05-24 | CNS HGG Temozolomide maintenance | N | N | 330013247 | NIVOLUMAB |
| 330013010 | 330008592 | 1.61 | 10.6 | Curative (C) | 2018-04-17 | 2018-04-17 | EW EuroEwing 99 : VIDE | 2 | N | 330013308 | EURO-EWING |
| 330013011 | 330004783 | 1.8 | 71.3 | Curative (C) | 2019-04-05 | 2019-06-17 | FLAG + Idarubicin | null | null | 330013538 | FLAG + IDARUBICIN |
| 330013013 | 330004801 | 1.33 | 78.5 | Palliative (P) | 2017-07-11 | 2017-07-13 | Etoposide oral | null | null | 330013757 | ETOPOSIDE |
| 330013014 | 330004814 | 1.68 | 104.9 | Curative (C) | null | 2018-04-09 | Vinblastine | null | null | 330013921 | VINBLASTINE |
| 330013015 | 330004820 | null | null | Palliative (P) | 2017-07-25 | 2017-08-07 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | null | 330013942 | TEMOZOLOMIDE |
| 330013016 | 330004833 | 1.72 | null | Curative (C) | 2015-07-22 | 2015-07-22 | LIPOSOMAL DOXORUBICIN | N | null | 330014044 | LIPOSOMAL DOXORUBICIN |
| 330013017 | 330004839 | 1.5 | 94.7 | null | 2014-03-12 | 2014-04-09 | CNS Low Grade Glioma Vinblastine | N | N | 330014135 | DA |
| 330013018 | 330004854 | 1.74 | null | Curative (C) | null | 2017-01-09 | TEMOZOLOMIDE | 02 | N | 330014295 | CISPLATIN + ETOPOSIDE |
| 330013020 | 330010697 | 1.58 | 37 | Palliative (P) | 2013-08-13 | 2014-01-10 | Docetaxel | 02 | N | 330014643 | DOCETAXEL |
| 330013022 | 330004915 | 1.61 | null | Palliative (P) | 2014-09-29 | 2014-09-29 | Docetaxel 75mg/m2 (21 day) | 2 | N | 330014897 | DOCETAXEL |
| 330013023 | 330010720 | 1.79 | 65 | Palliative (P) | 2016-10-24 | 2016-11-04 | EW EuroEwing 99 : VIDE | 02 | N | 330015177 | EURO-EWING |
| 330013024 | 330004964 | 1.74 | 64.4 | Palliative (P) | 2015-01-07 | 2015-05-22 | TEMOZOLOMIDE | 02 | N | 330015195 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330013025 | 330004993 | 1.78 | 71 | Palliative (P) | 2018-05-16 | 2018-05-16 | Docetaxel | 02 | N | 330015651 | DOCETAXEL |
| 330013026 | 330010736 | 1.77 | null | Palliative (P) | 2015-06-17 | 2015-06-25 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330015848 | LIPOSOMAL DOXORUBICIN |
| 330013027 | 330005011 | 1.74 | null | Palliative (P) | 2013-11-08 | 2014-04-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330015927 | DOCETAXEL |
| 330013028 | 330010739 | 1.52 | 55.95 | Curative (C) | 2015-02-14 | 2015-02-22 | FLAG + Idarubicin | N | Y | 330015927 | FLAG + IDARUBICIN |
| 330013029 | 330005023 | 0 | 52 | Curative (C) | 2016-12-13 | 2017-03-24 | DA 3+8 | 02 | Y | 330015996 | VINBLASTINE |
| 330013030 | 330005050 | 1.78 | null | Curative (C) | null | 2017-08-23 | Cyclophosphamide + Topotecan | 02 | N | 330016238 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330013031 | 330005111 | 0 | 70.2 | Palliative (P) | 2018-07-10 | 2018-07-11 | FLAG + Idarubicin | Y | N | 330016923 | FLAG + IDARUBICIN |
| 330013032 | 330005115 | 1.64 | 65 | null | 2014-09-08 | 2014-09-11 | Docetaxel 75mg/m2 (21 day) | N | N | 330016960 | DOCETAXEL |
| 330013033 | 330005120 | null | 69.1 | Curative (C) | null | 2014-06-24 | DA 3+8 | 02 | null | 330016972 | TEMOZOLOMIDE |
| 330013034 | 330005124 | 1.67 | 84.7 | Curative (C) | 2017-03-13 | 2018-01-30 | CVP R | Y | N | 330017013 | CAPECITABINE + CISPLATIN |
| 330013035 | 330013343 | 1.6 | null | Curative (C) | 2014-01-28 | 2014-01-29 | Carboplatin + Pemetrexed | N | N | 330017086 | DACTINOMYCIN + ETOPOSIDE |
| 330013037 | 330005159 | null | 49 | Adjuvant (A) | 2015-01-01 | 2015-03-09 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | null | 330017337 | CAPECITABINE + CISPLATIN |
| 330013038 | 330005181 | 1.84 | 65.7 | Adjuvant (A) | 2015-04-05 | 2015-04-17 | AML Int Guide ADE 8+3+5 (2) | N | null | 330017544 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 330013039 | 330005203 | 1.6 | null | null | 2017-08-13 | 2017-08-13 | NB BEACON Temozolomide Bevacizumab | 01 | N | 330017807 | DOXORUBICIN + GEMCITABINE |
| 330013040 | 330005211 | 1.23 | 72.8 | Curative (C) | null | 2017-10-03 | VIDE | Y | N | 330017874 | MAP + MIFAMURTIDE |
| 330013041 | 330005224 | 1.56 | 38.3 | Curative (C) | 2017-01-25 | 2017-02-25 | CARBOPLATIN + Procarbazine | null | null | 330018009 | CYTARABINE |
| 330013042 | 330005246 | null | 114 | Palliative (P) | 2016-08-09 | 2016-09-24 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | 330018401 | BEVACIZUMAB + IRINOTECAN |